Cargando…
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
Poor data have been previously reported about the mutation rates in K-RAS, BRAF, and PIK3CA genes among patients with hepatocellular carcinoma (HCC). Here we further elucidated the role of these genes in pathogenesis of primary hepatic malignancies. Archival tumour tissue from 65 HCC patients origin...
Autores principales: | Colombino, M, Sperlongano, P, Izzo, F, Tatangelo, F, Botti, G, Lombardi, A, Accardo, M, Tarantino, L, Sordelli, I, Agresti, M, Abbruzzese, A, Caraglia, M, Palmieri, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270270/ https://www.ncbi.nlm.nih.gov/pubmed/22258409 http://dx.doi.org/10.1038/cddis.2011.136 |
Ejemplares similares
-
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
por: Marra, Monica, et al.
Publicado: (2011) -
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas
por: Manca, Antonella, et al.
Publicado: (2015) -
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
por: Palomba, Grazia, et al.
Publicado: (2012) -
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
por: Palomba, Grazia, et al.
Publicado: (2016) -
EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)